Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Celltrion
With
Nippon Kayaku Co., Ltd.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patient who has histologically confirmed and newly diagnosed breast cancer
Patient who has clinical stage I, II, or IIIa operable breast cancer according to AJCC (American Joint Committee on Cancer) Breast Cancer Staging 7th edition
Patient who has HER2-positive status confirmed locally, defined as 3+ score by IHC (immuno-histochemistry).
You may not be if
Patient who has bilateral breast cancer
Patient who has received prior treatment for breast cancer, including chemotherapy, biologic therapy, hormone therapy, immunotherapy, radiation or surgery, including any prior therapy with anthracyclines.
Clareo Health | Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer
